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Abstract
Background: Context: Acute cough is a very common symptom presentation among children in
primary care and is usually due to respiratory infection, yet its cost is unknown. An estimate of the
cost to healthcare providers and parents would aid budgetary decision-making, and provide an
insight into the need for interventions to reduce the burden. Purpose: To estimate the cost per child
per episode, and the annual population cost in the UK, of acute cough in pre-school children
presenting to primary care.
Methods: Design: Incidence and prevalence-based cost-of-illness study from the perspectives of
the UK NHS and of parents and caregivers. Setting: 11 general practices in Bristol, UK. Subjects: 121
children without known asthma aged 3 to 59 months presenting for the first time with an acute (≤
28 days) cough.
Results: Mean cost per episode to the NHS: £27.43 (95% CI: £24.38 – £30.49). Mean cost per
episode to parents and carers: £14.77 (£4.90 – £24.65). Annual cost to the NHS in the UK: at least
£31.5 m (95% CI: £28.0 m – £35.0 m).
Conclusion: The cost burden on the healthcare provider of acute cough in pre-school children is
substantial; the majority of this cost arises from consultations with general practitioners. Parents
experience some personal cost through travel and expenditure on over-the-counter preparations,
and may suffer significantly if loss of earnings is experienced. There is scope for evaluating
interventions designed to reduce this burden.
Background
Cough in children is the most commonly managed symp-
tom in the NHS [1] and is usually associated with viral
infection [2]. This is likely to generate a considerable cost
burden as suggested by Ehlken et al [3], who estimated the
mean cost of an episode of lower respiratory tract infec-
tion in children under the age of three treated as outpa-
tients in Germany, Lambert et al [4], whose cohort study
of children aged between 12 and 71 months estimated the
cost of a community-managed episode of respiratory viral
infection, and Fendrick [5] who conducted a study of viral
respiratory tract infection in the general population of the
USA. These studies vary in their scope and settings but
there is agreement about the importance of the cost to
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knowledge no research to date has attempted to estimate
the scale of this burden in the UK. An estimate of these
costs would indicate the relative importance of this issue
to policy makers, clinicians, and parents. It would provide
information to aid budgetary decision-making, and
insight into the need for interventions to reduce the cost
burden. The aim of this study was to estimate the annual
cost to the National Health Service (NHS) in the UK, and
the direct cost per episode to parents and carers, of acute
cough in pre-school children presenting to primary care.
Methods
This study was part of a larger cohort study designed to
validate a clinical rule for predicting complications of
acute cough in pre-school children [6]. Within this frame-
work we carried out a cost-of-illness study on those chil-
dren presenting for the first time for that episode of
illness. This was conducted from the perspectives of the
NHS and parents and caregivers. We estimated the cost to
the NHS of an episode of illness and combined it with
data from the literature to estimate the annual cost burden
to the NHS in the UK. We also estimated the cost per epi-
sode incurred by parents and carers of children with acute
cough. Participants included children without known
asthma or other chronic disease aged 3 to 59 months who
presented to 11 general practices in Bristol between Sep-
tember 2004 and May 2005, for the first time with an
acute (≤ 28 days) cough.
Identification of resource use and data collection
The provider perspective included all resources supplied
by the NHS and used by participants during the period
between the index consultation and cough resolution up
to a maximum of four weeks following the initial consul-
tation. These were identified as: practice based consulta-
tions with a doctor or nurse; telephone consultations;
home visits; visits to a Walk-in Centre; contacts with NHS
Direct; out-of-hours care including telephone consulta-
tion, face-to-face consultation and home visits; visits to
A&E; out-patient appointments; in-patient hospital care;
and prescribed medication.
From the perspective of the parents and caregivers, the rel-
evant direct costs included: travel to health care facilities
for visits associated with the child's cough; over-the coun-
ter medication purchased; extra care for dependents
required because of the child's illness; and loss of earnings
as a result of the child's illness.
Data on resource use were collected using a telephone
questionnaire. A researcher contacted parents and carers
weekly and asked about any contacts with a health care
professional and any prescriptions received during the
previous week. They were also asked about mode of travel
and the cost of fares when visiting health care facilities,
expenditure on over-the-counter preparations for cough,
how much they had lost in terms of earnings foregone
because of their child's illness, and any extra expenditure
on child or other dependent care.
Valuation of resources
All resources were valued in pounds sterling at 2006
prices. Unit costs and their source are given in Table 1.
Resource use was valued using recognised sources of unit
costs. Primary care contacts were valued using Curtis and
Netten [7] and visits to the walk-in centre were valued
using information from the national evaluation of first-
wave walk-in centres [8]. Hospital-based care was valued
using the NHS tariff [9], and for prescribed medication we
used costs reported in the British National Formulary
[10]. The AA schedule of motoring costs [11] was used to
cost the use of cars for travel. Unit costs were adjusted,
where necessary, using an appropriate inflation index [7].
No discounting was necessary as the time period involved
was one month.
Estimating the annual cost to the NHS
The estimated cost per episode to the NHS from the cost-
of-illness study was combined with estimates from the lit-
erature and routine sources to estimate the annual cost to
Table 1: Source and value of unit costs
£ Source Details
GP at surgery 21.00 Curtis and Netten 2006 [7] Includes direct care staff costs but excludes cost of training
Nurse at surgery 8.00 Curtis and Netten 2006 [7]
GP telephone consultation 23.00 Curtis and Netten 2006 [7] Includes direct care staff costs but excludes cost of training
GP home visit 60.00 Curtis and Netten 2006 [7] Includes direct care staff costs but excludes cost of training
Walk-in centre (WiC) with a nurse 28.91 WiC evaluation [8] Mean of shop front & GP based, inflated to 2006
A & E visit 70.62 NHS Tariff [9] A & E weighted average of referred/discharged using 2004 volume 
proportions
Out-patient appointment 19.85 NHS Tariff [9] Band A x-ray cost in 2004 inflated
Prescribed medication British National Formulary [10]
Mileage 0.49 The AA [11] Mean of mid-price car; 10,000 – 15,000 miles pa; petrol & dieselPage 2 of 6
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cough. The annual population cost was estimated as:
(cost per episode per child consulting) × (mean number 
of episodes per annum) × (population)
The mean number of episodes per annum is a combina-
tion of the number of (different) children consulting with
a cough in any year and the mean number of episodes of
illness per child per annum. There is evidence in the liter-
ature of the number of children consulting with one or
more episodes of cough in any year [12], but we were una-
ble to find evidence on the mean number of episodes of
cough per child per annum. We therefore used a conserv-
ative estimate of one for our baseline analysis. The
number of children in the UK under the age of five was
taken from the Office of National Statistics [13]. All anal-
yses were carried out using Microsoft Excel and Stata (ver-
sion 9).
Results
Participant characteristics
Two hundred and fifty six eligible children were invited to
take part in the cohort study to validate the prediction
rule. Fifty-nine (23%) refused and 33 (13%) were unable
to read or write English. Of the 164 recruited, 13 (8%)
failed to complete or provide data and 30 (18%) were not
consulting for the first time. Thus 121 children were suit-
able for inclusion in the cost-of-illness study. Recruitment
was through general practices covering a broad socio-
demographic spectrum. Compared with the general pre-
school population our sample of children was a little
younger (73% under the age of three compared with
61%) and contained more boys (56% vs. 51%). It was
predominantly white (76%), though probably less than
the general population (92% white in the UK at the 2001
census), with the remaining children split between a range
of ethnic groups. Diagnostic labels assigned by the GPs
(95%) or nurses (5%) seeing the children were: upper res-
piratory tract infection (64%), lower respiratory tract
infection (9%), bronchiolitis (5%), bronchitis (4%),
croup (3%), respiratory tract infection with bronchos-
pasm (3%) and other (10%).
Resource use
The mean resource use per child per episode, by item, is
given in Table 2. One hundred and three (85%) children
had only one primary care contact, thus the re-consulta-
tion rate was 15%. Nearly all (95%) of the primary care
contacts were with a GP, the remainder with a nurse. One
child visited A&E, and one child had an outpatient
appointment for a chest x-ray. Prescriptions were issued to
58 (48%) children, with 36 (30%) receiving antibiotics.
Parents of 35 (29%) children bought at least one over-the-
counter preparation, with one parent purchasing four.
Twenty-five (21%) parents reported losing income
because of their child's illness and of these, two days off
work was most common.
Cost per episode
The mean cost per child per episode is given in Table 3.
Including the initial consultation and during the period
prior to cough resolution, the mean cost to the NHS per
child was £27.43 (95% CI: £24.38, £30.49). Primary care
accounted for 93% of this, with GP consultations costing
£22.91 (£21.08, £24.73). Secondary care and prescribed
medication costs were small. The mean cost per episode to
parents and caregivers was £14.77 (£4.90, £24.65). Lost
earnings accounting for the greatest part (85%) though
there was considerable variation of experience among
families. Mean expenditure per child on over-the-counter
preparations was £1.32 (£0.89, £1.76), with the average
purchase cost of a single preparation being £3.08 (£2.84,
3.32).
Annual cost to the NHS
We combined the cost per episode results with data on
incidence and population. Evidence suggests that around
333 per thousand (i.e. a third) children under the age of
five consult in primary care with cough at least once a year
[12]. The population of under-fives in the UK in 2005 was
3.43 m [13]. Thus the annual cost to the NHS in 2006 was
at least £31.5 m (95% CI: £28.0 m to £35.0 m).
Sensitivity analysis
There are a number of reasons why our population cost
estimate may be conservative and the effect of two of these
is explored here. First, the cost per episode is based on the
empirical work reported here. In our study the reconsulta-
Table 2: Mean resource use per episode per participant
Item of resource use Mean (sd)
Primary Care
GP consultations 1.09 (0.48)
Nurse consultations 0.06 (0.23)
Telephone consultations 0.02 (0.13)
Home visits 0.01 (0.09)
Walk-in Centre visits 0.02 (0.13)
Secondary Care
A & E visits 0.01 (0.09)
Out-patients appointments 0.01 (0.09)
Prescriptions 0.58 (0.69)
Parental resource use
Primary care journeys 0.61 (0.62)
Secondary care journeys 0.02 (0.13)
Over-the-counter medication 0.43 (0.78)
Days off work 0.64 (1.71)Page 3 of 6
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range of reconsultation rates that include 17% [14] and
24% [15] in children with acute upper respiratory tract
infection. Using a re-consultation rate of 20%, which may
be more realistic, the population cost estimate rises to
£32.7 m. Second, although we know that children experi-
ence between three and six respiratory tract infections per
annum [2], we were unable to find evidence of the mean
number of episodes of cough for which a child consults
each year. We used an estimate of one but if 10% of chil-
dren had consulted for two episodes of illness in a year,
the annual cost estimate rises to £34.6 m.
Discussion
The cost burden to the NHS of acute cough in pre-school
children, at over £30 m, is substantial and the majority of
this cost arises from consultations with general practition-
ers. This cost represents 1.3 million consultations each
year in the UK. Parents experience some personal cost
through travel and expenditure on over-the-counter prep-
arations, and may suffer significantly if loss of earnings is
experienced.
We have highlighted a number of reasons why our esti-
mate may be conservative. A further factor is the limita-
tion of our recruitment strategy. We were only able to
recruit children who presented to primary care during
normal office hours, thus children presenting initially to
A&E or to out-of-hours primary care providers were not
included. These children are likely to have more serious
illness and may represent a greater cost burden. Also, we
only included resource use from the time of the first GP
consultation so any use of healthcare prior to that point
will have been excluded. In addition, our cost estimate is
limited by the poor data on indirect costs. Whilst we were
able to estimate the direct cost to parents of time off work,
the societal cost of that time is unknown. In total, the time
off work due to childhood cough is substantial though
this composed of a large number of short periods of
absenteeism. The valuation of productivity loss is conten-
tious and several methods have been proposed [16], the
most appealing for pragmatic research being the friction
cost method, a variation of the human capital approach,
which includes only the resources required to replace the
employee. Because of the disparate nature of the absentee-
ism here it is impossible to estimate the cost of lost pro-
ductivity using the friction cost method without more
detailed information on how the absenteeism was dealt
with by employers. This conservative approach means
that the true cost to society, including the cost of lost pro-
ductivity, would also inflate the estimate. Despite this, our
results are useful in indicating the cost burden of acute
cough to the NHS and to parents and caregivers, and there
is face validity to these estimates when compared with
those of a recent study of the minimum cost of preschool
asthma and wheeze [17]. Other studies of the cost of res-
piratory tract infections concur. Although they address
different patient groups in different settings, the studies by
Ehlken [3] and Lambert [4] also suggest our estimates may
be conservative.
There is very little information available to compare the
cost of cough with other reasons children consult in gen-
eral practice. The most common symptoms are: stomach
ache, fever, rash, and diarrhoea and vomiting [12].
Unpublished results of a current study indicate the cost to
the NHS in the UK of fever in pre-school children is likely
to be less than that of cough due to lower consultation
rates per episode of illness and lower prevalence. Another
common reason for children to use primary care is for
routine immunisations. The cost of these is around £40
per child over the first five years of life, suggesting an
annual cost to the NHS similar to that found here.
As recommended by the Medical Research Council [18],
we chose a symptom (cough) rather than diagnosis or dis-
ease-based entry criterion for this study because of the
inconsistency of diagnostic label use for respiratory tract
infections in primary care [19]. Our study could therefore
be regarded as a 'cost of symptom' study (rather than 'cost
of illness'). Nevertheless, interpretation of the results is
Table 3: Mean cost per episode per participant
Item of resource use Mean and (sd) cost (£)
Primary Care
GP consultations 22.91 (10.14)
Nurse consultations 0.46 (1.88)
Telephone consultations 0.38 (2.94)
Home visits 0.50 (5.45)
Walk-in Centre visits 0.48 (3.70)
Total primary care 24.73 (12.75)
Secondary Care
A & E visits 0.58 (6.42)
Out-patients appointments 0.16 (1.80)
Total secondary care 0.75 (6.65)
Prescribed medication 1.96 (3.54)
Total NHS costs 27.43 (16.99)
Parent and caregiver costs
Primary care travel 0.78 (1.21)
Secondary care travel 0.11 (0.90)
Over-the-counter medication 1.32 (2.43)
Lost earnings 12.56 (54.64)
Total parent and care-giver costs 14.77 (54.84)Page 4 of 6
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ness' that instigates the consultation and any intervention
designed to reduce consultation rates would need to target
the symptom (cough). Cost-of-illness studies can be
viewed as being 'incidence based' or 'prevalence based'
[20] and each has a different value to planners of health
care services. Here we have performed both types of study
by estimating the cost per episode of illness and the
annual cost burden to the NHS. The prevalence approach
indicates the overall scale of the cost burden, allows for
comparison with other areas of health care, and can
inform decisions as to whether cost savings are possible
and/or desirable. Although as Fleurence and Torgerson
[21] point out, one disadvantage of cost of illness studies
is the limited extent to which they can inform the research
agenda, this study shows that information provided by
such a study is necessary if not sufficient to evaluate the
need for future research.
The incidence approach is useful from an intervention
perspective, indicating the scope for cost savings as a result
of different treatment alternatives. There is evidence that
delayed prescribing supported by patient information
leaflets can affect healthcare-seeking behaviour [22], and
information leaflets alone can affect reconsultation rates
and patient behaviour [23,24]. Although no study has
focussed on young children with cough there is an indica-
tion that such interventions could reduce antibiotic use
and reconsultation rates considerably without affecting
clinical outcomes [25]. In this study, if antibiotic use and
reconsultations had been 50% lower, our estimate of cost
per episode would be £2.04 lower and the annual cost to
the NHS reduced by £2.3 m to £29.1 m. Therefore, an
intervention costing less than £2.3 m, which reduces re-
consultations by 50%, would be cost saving. Furthermore,
delayed prescribing can change patient attitudes and
lessen the need to consult in the future thus reducing costs
to the NHS even further, though possibly at the expense of
parents.
This study raises several questions that could be addressed
by future research. Cost of illness studies address only the
cost of a disease, (or as in this case, a symptom). They do
not address outcomes and do not compare the cost and
outcomes of alternative strategies, as an economic evalua-
tion would. In order to assess the full significance of the
results the costs need to be considered in the light of ben-
efits arising from the expenditure. Most of the cost is gen-
eral practitioner time so the benefits of a consultation
must be identified. Two main outcomes are likely to be:
reassurance for parents anxious to confirm that the illness
is self-limiting; and the identification of children who are
seriously ill, for example, have pneumonia, an infectious
illness such as whooping cough, or have asthma. The
value of these benefits is unknown and subjective.
Efficiency in delivering healthcare can be addressed by
improving benefits or reducing the level of resource use or
both. Exploiting the skill-mix within a practice could
reduce resources used in delivering primary care to young
children with cough. Practice nurses, trained to identify
symptoms of serious illness, could be used to provide
reassurance and deliver an educational intervention
designed to inform parents about the likelihood of acute
cough developing into a more serious condition and the
symptoms that indicate deterioration. Although there is
uncertainty about the overall relative cost-effectiveness of
nurses and doctors in primary care [26], matching tasks to
skills and experience may result in more efficient use of
staff resources.
Conclusion
This study has estimated the cost of one of the major rea-
sons that children use primary care. The scale of this bur-
den is large and indicates there is scope for evaluating the
effectiveness and cost-effectives of interventions designed
to reduce this burden.
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